AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitaglyn M 100/500 Tablet ER

Prescription Icon
Prescription Required

Marketer

Zydus Healthcare Limited

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Sitaglyn M 100/500 Tablet ER

DiaGlym ER 100/500 tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, and may lessen the risk of stroke or heart attack. DiaGlym ER 100/500 may be used independently or in conjunction with other diabetes treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood glucose levels, and existing medications. Consuming the tablets with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your physician’s guidance. Adherence to your doctor’s recommended diet and exercise plan is crucial for successful diabetes management; lifestyle significantly impacts blood sugar control. Common side effects include nausea, diarrhea, vomiting, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, especially when combined with insulin or sulfonylureas; learn to recognize and manage this. This medication isn't suitable for all patients. Inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting. Pregnant or breastfeeding individuals should consult their doctor. Other medications may interact with DiaGlym ER 100/500; provide a complete medication list to ensure safety. Alcohol should be limited due to its blood glucose-lowering effect. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Uses of Sitaglyn M 100/500 Tablet ER

Managing type 2 diabetes

Major Benefits of Sitaglyn M 100/500 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. It's recommended to take Sitaglyn M 100/500 Tablet ER with a meal.

Common Side effects of Sitaglyn M 100/500 Tablet ER:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglyn M 100/500 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sitaglyn M 100/500 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Sitaglyn M 100/500 Tablet ER works:

Sitaglyn M 100/500 ER tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual-action approach leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Sitaglyn M 100/500 Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaglyn M 100/500 Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Sitaglyn M 100/500 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Sitaglyn M 100/500 Tablet ER cautiously, potentially requiring dosage modification. Consult a physician before use. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Extended-release Sitaglyn M 100/500 tablets are likely contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Sitaglyn M 100/500 Tablet ER :

Should you forget to take a Sitaglyn M 100/500 Tablet ER, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Sitaglyn M 100/500 Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Treatment

FAQs on Sitaglyn M 100/500 Tablet ER

Sitaglyn M 100/500 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitaglyn M 100/500 Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitaglyn M 100/500 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients allergic to Sitaglyn M 100/500 Tablet ER components or excipients should not use it. This medication is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglyn M 100/500 Tablet ER with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitaglyn M 100/500 Tablet ER) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaglyn M 100/500 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaglyn M 100/500 Tablet ER may cause common side effects including hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis can occur. Prolonged use may also result in vitamin B12 deficiency.
Patients with allergies to Sitaglyn M 100/500 Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitaglyn M 100/500 Tablet ER with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (Sitaglyn M 100/500 Tablet ER) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect necessitates avoiding this medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitaglyn M 100/500 Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaglyn M 100/500 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaglyn M 100/500 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitaglyn M 100/500 Tablet ER is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglyn M 100/500 Tablet ER with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitaglyn M 100/500 Tablet ER) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume large quantities of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitaglyn M 100/500 Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues like numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaglyn M 100/500 Tablet...
190